JAGSONPAL PHARMACEUTICALS
|
The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 34.43.
| Share Price | ₹237.6 | Aug 06,2026 |
| Market Cap | ₹1,565.8 Cr | |
| Earnings-TTM | ₹45.5 Cr | TTM-Standalone Results |
| Price/Earnings | 34.43x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,565.8 Cr] as on Aug 06,2026
(/) Earnings [ ₹45.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 34.43x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 34.43 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS
PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 24.66x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 25.9x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 43.57x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 12.22x.
How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| JAGSONPAL PHARMACEUTICALS | 45.48 | 34.43 | 1,565.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 38.32 | 466,431.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 75.25 | 220,115.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 87.59 | 188,853.0 |
| CIPLA LTD | 3,364.84 | 35.41 | 119,158.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.95 | 98,074.4 |
| MANKIND PHARMA LTD | 2,055.11 | 48.85 | 100,395.0 |
| LUPIN LTD | 5,355.47 | 20.42 | 109,348.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.95 | 110,349.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 24.63 | 91,456.3 |
| LAURUS LABS LTD | 1,090.76 | 90.95 | 99,201.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.42x |
| Max industry PE | 90.95x |
| Median industry PE | 35.41x |
| Average industry PE | 46.25x |
You may also like the below Video Courses